n(4)-hexadecyl-1-arabinofuranosylcytosine and Hemolysis

n(4)-hexadecyl-1-arabinofuranosylcytosine has been researched along with Hemolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horber, DH; Odermatt, B; Schott, H; Schwendener, RA	1

Other Studies

1 other study(ies) available for n(4)-hexadecyl-1-arabinofuranosylcytosine and Hemolysis

Article	Year
Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine. Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytarabine; Drug Carriers; Female; Hemolysis; Humans; Leukemia L1210; Liposomes; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Tissue Distribution	1996

Article

Year

Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine.

Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:2

Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytarabine; Drug Carriers; Female; Hemolysis; Humans; Leukemia L1210; Liposomes; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Tissue Distribution

1996